12:00 AM
Jan 14, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Melphalan intraocular injection regulatory update

Icon said FDA granted Orphan Drug designation for melphalan intraocular injection to treat retinoblastoma. The product, which...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >